首页> 外文期刊>Medicine. >Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors <= 5cm in the Modern Treatment Era: A Retrospective Korean Breast Cancer Society Report
【24h】

Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors <= 5cm in the Modern Treatment Era: A Retrospective Korean Breast Cancer Society Report

机译:乳腺癌后乳腺癌患者患有1至3个阳性腋窝节点和肿瘤的应用趋势<= 5cm在现代治疗时代:回顾性韩国乳腺癌社会报告

获取原文
获取原文并翻译 | 示例
           

摘要

Despite high-level evidence, the benefit of postmastectomy RT in these patients in recent years has not been fully elucidated. We investigated postmastectomy radiotherapy (RT) use and evaluated clinicopathologic and treatment factors influencing RT use in Korean women with pT1-2N1 breast cancer.We identified women diagnosed with pT1-2N1 breast cancer between 1994 and 2009 using the Korean Breast Cancer Registry. Factors associated with RT use were evaluated using logistic regression analysis. The median follow-up was 95 months.Of the 6196 women, 11.9% underwent postmastectomy RT. RT was applied more frequently in women with 3 positive lymph nodes (adjusted odds ratio [OR], 2.69) and larger tumors (OR per centimeter, 1.10). RT use was not significantly associated with well-established risk factors (e.g., tumor grade, hormone receptor status, and lymphovascular space invasion). Although RT utilization increased gradually during the study period (OR per year, 1.07), factors associated with RT were similar over time. The estimated 5-year overall survival increased significantly from 84.1% in 1994 to 2000 to 94.6% in 2005 to 2009.This population-based analysis revealed that the indications for postmastectomy RT in pT1-2N1 breast cancer in Korea are based solely on conventional anatomical factors, although their survival has increased significantly in the modern treatment era. There is a significant unmet need for better risk stratification in these patients and for tailored RT with the incorporation of tumor biology-associated factors.
机译:尽管有高级别的证据,但近年来这些患者在这些患者中的益处尚未完全阐明。我们调查了后切除放射治疗(RT)使用和评估影响韩国女性RT使用RT的临床病理和治疗因素,PT1-2N1乳腺癌。我们使用韩国乳腺癌登记处诊断患有PT1-2N1乳腺癌的女性。使用Logistic回归分析评估与RT使用相关的因素。中位后续时间为95个月。6196名女性,11.9%的后期后切除术。在具有3个阳性淋巴结的女性中更频繁地施用RT(调整的差异率[或],2.69)和较大的肿瘤(或每厘米,1.10)。 RT使用没有明显与良好的危险因素有显着相关(例如,肿瘤级,激素受体状态和淋巴血管空间入侵)。尽管在研究期间(或每年1.07)期间,RT利用逐渐增加,但随着时间的推移,与室温相关的因素相似。估计的5年总生存率从1994年到2005年的84.1%增加到2005年至2009年的94.6%。基于人口的分析表明,韩国PT1-2N1乳腺癌中的后切除术治疗术后的适应症是完全基于常规解剖学虽然他们的生存在现代治疗时代的生存率显着增加了因素。在这些患者中具有更好的风险分层并具有掺入肿瘤生物学相关因素的风险分层的明显需求。

著录项

  • 来源
    《Medicine.》 |2016年第19期|共10页
  • 作者单位

    Yonsei Univ Coll Med Dept Radiat Oncol Seoul 120752 South Korea;

    Yeungnam Univ Coll Med Dept Surg Daegu South Korea;

    Chonnam Natl Univ Sch Med Dept Surg Gwangju South Korea;

    Chonbuk Natl Univ Sch Med Dept Surg Jeonju 561756 Jeonbuk South Korea;

    Catholic Univ Korea Coll Med Dept Radiat Oncol Seoul South Korea;

    Yonsei Univ Coll Med Dept Surg Seoul 120752 South Korea;

    Yonsei Univ Coll Med Dept Surg Seoul 120752 South Korea;

    Yonsei Univ Coll Med Dept Radiat Oncol Seoul 120752 South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号